Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)

v3.22.1
SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]    
From operating activities $ (34,372) $ (7,919)
From investing activities (9,012) (4,075)
From financing activities 48,731 6,740
Effect of foreign exchange on cash and cash equivalents (329) 213
Net increase in cash and cash equivalents 5,018 (5,041)
Focus Medical Herbs Ltd [Member]    
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]    
From operating activities 2,346 1,882
From investing activities (783) (1,656)
From financing activities 560 (184)
Effect of foreign exchange on cash and cash equivalents 169 39
Net increase in cash and cash equivalents $ 2,292 $ 81